pyrroles has been researched along with Cardiac Diseases in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 15 (51.72) | 29.6817 |
| 2010's | 12 (41.38) | 24.3611 |
| 2020's | 2 (6.90) | 2.80 |
| Authors | Studies |
|---|---|
| Bora, V; Goyal, RK; Johar, K; Patel, BM; Patel, D | 1 |
| Akaike, T; Kuga, K; Kusakari, Y; Minamisawa, S; Semba, K; Uesugi, K; Urashima, T | 1 |
| Angus, SP; Beak, JY; Chen, X; Hicks, ST; Huang, W; Jensen, BC; Johnson, GL; Parry, TL; Sciaky, N; Stuhlmiller, TJ; Willis, MS; Zawistowski, JS | 1 |
| Campbell, SM; Godman, B; Gustafsson, LL; Pichetti, S; Sermet, C | 1 |
| Drechsler, C; Genser, B; Hengstschläger, M; Kaltenecker, CC; Kopecky, C; Krane, V; März, W; Säemann, MD; Wanner, C; Weichhart, T | 1 |
| Chen, H; Chen, Y; Cui, G; Cui, W; Fang, J; Guo, X; Lee, SM; Liu, A | 1 |
| Coker, SJ; Currie, S; Mooney, L; Skinner, M | 1 |
| Aramburu, O; Arévalo, M; Arias, JL; Blanca, AJ; Mate, A; Miguel-Carrasco, JL; Ruiz-Armenta, MV; Vázquez, CM; Zambrano, S | 1 |
| Al-Khayatt, MS; Brull, DJ; Campbell, VL; O'Mahony, C | 1 |
| Chen, MH | 1 |
| Breazna, A; Deedwania, PC; DeMicco, DA; Greten, H; LaRosa, JC; Shepherd, J; Wenger, NK | 1 |
| Lopatin, IuM | 1 |
| Berkin, L; Brown, JE; Collinson, FJ; Khan, MM; Selby, PJ; Vasudev, NS | 1 |
| Takagi, H; Umemoto, T | 1 |
| Telli, M; Witteles, RM | 1 |
| Corso, G; Di Mare, G; Lambert, Y; Marrelli, D; Mastrogiacomo, D; Neri, A; Roviello, F; Volterrani, L | 1 |
| Beevers, DG; Lim, HS; Lip, GY; Nadar, S | 1 |
| Gross, B; Hättenschwiler, A; Schulthess, G; Widmer, Ch | 1 |
| Krane, V; Mann, JF; März, W; Olschewski, M; Ritz, E; Ruf, G; Wanner, C | 1 |
| Damkier, P; Hallas, J; Korsholm, L; Kristensen, SR; Mickley, H; Poulsen, TS; Vinholt, P | 1 |
| Sanford, A; Wilson, SA | 1 |
| Candura, D; Chello, M; Covino, E; D'Ambrosio, A; Di Sciascio, G; Pasceri, V; Patti, G | 1 |
| Honey, K | 1 |
| Messerli, FH | 1 |
| Force, T; Krause, DS; Van Etten, RA | 1 |
| Kulbertus, H | 1 |
| Braunwald, E | 1 |
| Bax, JJ; Davignon, J; Dunkelgrun, M; Feringa, HH; Hoeks, SE; Kastelein, JJ; Poldermans, D; Schouten, O; van Domburg, RT; Vidakovic, R; Welten, GM | 1 |
| Staehler, M | 1 |
4 review(s) available for pyrroles and Cardiac Diseases
| Article | Year |
|---|---|
Cardiac dysfunction induced by novel targeted anticancer therapy: an emerging issue.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzenesulfonates; Dose-Response Relationship, Drug; Drug Delivery Systems; Female; Heart; Heart Diseases; Heart Failure; Humans; Indoles; Male; Neoplasms; Niacinamide; Phenylurea Compounds; Prognosis; Protein Kinase Inhibitors; Pyridines; Pyrroles; Risk Assessment; Sorafenib; Sunitinib; Survival Analysis; Trastuzumab | 2009 |
Atorvastatin decreases lipoprotein(a): a meta-analysis of randomized trials.
Topics: Anticholesteremic Agents; Atorvastatin; Heart Diseases; Heptanoic Acids; Humans; Hyperlipidemias; Lipoprotein(a); Pyrroles; Randomized Controlled Trials as Topic; Risk Factors | 2012 |
Amlodipine/atorvastatin (Caduet) for preventing heart disease.
Topics: Amlodipine; Drug Combinations; Heart Diseases; Heptanoic Acids; Humans; Pyrroles; Treatment Outcome | 2006 |
Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition.
Topics: Adaptor Proteins, Signal Transducing; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzenesulfonates; Drug Delivery Systems; Enzyme Inhibitors; Heart; Heart Diseases; Humans; Indoles; Lapatinib; Models, Biological; Neoplasms; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-abl; Pyridines; Pyrroles; Quinazolines; Sorafenib; Sunitinib; Trastuzumab | 2007 |
5 trial(s) available for pyrroles and Cardiac Diseases
| Article | Year |
|---|---|
Quantification of HDL proteins, cardiac events, and mortality in patients with type 2 diabetes on hemodialysis.
Topics: Aged; Atorvastatin; Biomarkers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Female; Germany; Heart Diseases; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Lipoproteins, HDL; Male; Middle Aged; Proportional Hazards Models; Pulmonary Surfactant-Associated Protein B; Pyrroles; Renal Dialysis; Risk Factors; Serum Amyloid A Protein; Time Factors; Treatment Outcome | 2015 |
Comparison of 80 versus 10 mg of atorvastatin on occurrence of cardiovascular events after the first event (from the Treating to New Targets [TNT] trial).
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Coronary Disease; Coronary Restenosis; Diabetes Complications; Double-Blind Method; Drug Administration Schedule; Heart Diseases; Heart Failure; Heptanoic Acids; Humans; Metabolic Syndrome; Pyrroles; Risk Factors; Treatment Outcome | 2010 |
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.
Topics: Aged; Atorvastatin; Cerebrovascular Disorders; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Heart Diseases; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Pyrroles; Renal Dialysis; Stroke | 2005 |
Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study.
Topics: Aged; Atorvastatin; Atrial Fibrillation; C-Reactive Protein; Cardiac Surgical Procedures; Cerebrovascular Disorders; Female; Heart Diseases; Heptanoic Acids; Humans; Length of Stay; Male; Middle Aged; Postoperative Complications; Pyrroles | 2006 |
Drug designed to raise HDL levels falls down.
Topics: Anticholesteremic Agents; Atorvastatin; Cholesterol Ester Transfer Proteins; Drug Industry; Heart Diseases; Heptanoic Acids; Humans; Lipoproteins, HDL; Pyrroles; Quinolines | 2007 |
20 other study(ies) available for pyrroles and Cardiac Diseases
| Article | Year |
|---|---|
Systemic study of selected histone deacetylase inhibitors in cardiac complications associated with cancer cachexia.
Topics: Animals; Benzamides; Butyric Acid; Cachexia; Cell Line, Tumor; Disease Models, Animal; Disease Progression; Female; Heart Diseases; Histone Deacetylase Inhibitors; Hydroxamic Acids; Male; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasms; Pyridines; Pyrroles | 2022 |
Fibrosis growth factor 23 is a promoting factor for cardiac fibrosis in the presence of transforming growth factor-β1.
Topics: Actins; Animals; Cells, Cultured; Disease Models, Animal; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibrosis; Heart Diseases; Male; Myocytes, Cardiac; Pyrroles; Rats; Rats, Sprague-Dawley; Receptor, Fibroblast Growth Factor, Type 1; Transforming Growth Factor beta1; Up-Regulation | 2020 |
Kinome and Transcriptome Profiling Reveal Broad and Distinct Activities of Erlotinib, Sunitinib, and Sorafenib in the Mouse Heart and Suggest Cardiotoxicity From Combined Signal Transducer and Activator of Transcription and Epidermal Growth Factor Recepto
Topics: Animals; Antineoplastic Agents; Cardiotoxicity; Cells, Cultured; Dose-Response Relationship, Drug; Echocardiography; ErbB Receptors; Erlotinib Hydrochloride; Fatty Acids; Female; Gene Expression Profiling; Heart; Heart Diseases; Indoles; Mice; Molecular Targeted Therapy; Myocardial Contraction; Myocardium; Myocytes, Cardiac; Niacinamide; Oxidation-Reduction; Phenylurea Compounds; Protein Interaction Maps; Protein Kinase Inhibitors; Proteomics; Pyrroles; Rats, Sprague-Dawley; Signal Transduction; Sorafenib; STAT3 Transcription Factor; Sunitinib; Time Factors | 2017 |
Multilevel analysis of the influence of patients' and general practitioners' characteristics on patented versus multiple-sourced statin prescribing in France.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Atorvastatin; Diabetes Mellitus; Drug Prescriptions; Drugs, Generic; Fatty Acids, Monounsaturated; Female; Fluorobenzenes; Fluvastatin; France; General Practitioners; Heart Diseases; Heptanoic Acids; Humans; Indoles; Lipid Metabolism Disorders; Male; Middle Aged; Models, Statistical; Practice Patterns, Physicians'; Pravastatin; Prescription Drugs; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Simvastatin; Sulfonamides | 2013 |
FGF2 Prevents Sunitinib-Induced Cardiotoxicity in Zebrafish and Cardiomyoblast H9c2 Cells.
Topics: Angiogenesis Inhibitors; Animals; Cardiotoxicity; Cell Line; Cell Line, Tumor; Cyclic AMP Response Element-Binding Protein; Fibroblast Growth Factor 2; Heart Diseases; Heart Rate; Humans; Indoles; Molecular Docking Simulation; Myoblasts; Phospholipase C gamma; Pyrroles; raf Kinases; Receptor, Fibroblast Growth Factor, Type 1; Sunitinib; Zebrafish | 2016 |
Effects of acute and chronic sunitinib treatment on cardiac function and calcium/calmodulin-dependent protein kinase II.
Topics: Animals; Blood Pressure; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Drug Administration Schedule; Guinea Pigs; Heart Diseases; Heart Rate; Indoles; Male; Pyrroles; Sunitinib; Treatment Outcome | 2015 |
Inflammatory and fibrotic processes are involved in the cardiotoxic effect of sunitinib: Protective role of L-carnitine.
Topics: Animals; Antineoplastic Agents; Blood Pressure; Cardiotonic Agents; Cardiotoxicity; Carnitine; Cytokines; Endomyocardial Fibrosis; Gene Expression; Heart Diseases; Indoles; Male; Myocarditis; Myocytes, Cardiac; NF-kappa B; Pyrroles; Rats; Rats, Wistar; RNA, Messenger; Sunitinib | 2016 |
Rhabdomyolysis with atorvastatin and fusidic acid.
Topics: Aged; Anti-Bacterial Agents; Atorvastatin; Drug Interactions; Drug Therapy, Combination; Floxacillin; Fusidic Acid; Heart Diseases; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Osteomyelitis; Pyrroles; Rhabdomyolysis | 2008 |
[How to increase the adherence to treatment of patients with arterial hypertension and dyslipidemia: focus on fixed combination of amlodipine and atorvastatin].
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Antihypertensive Agents; Atorvastatin; Calcium Channel Blockers; Diuretics; Drug Combinations; Drug Monitoring; Drug Synergism; Dyslipidemias; Heart Diseases; Heptanoic Acids; Humans; Hypertension; Patient Compliance; Pyrroles; Risk Factors | 2010 |
Sunitinib-induced severe hypothyroidism with cardiac compromise.
Topics: Heart Diseases; Humans; Hypothyroidism; Indoles; Male; Middle Aged; Pyrroles; Severity of Illness Index; Sunitinib | 2011 |
Underestimating cardiac toxicity in cancer trials: lessons learned?
Topics: Angiogenesis Inhibitors; Clinical Trials as Topic; Drug Labeling; Drug Monitoring; Heart Diseases; Humans; Indoles; Neoplasms; Pyrroles; Stroke Volume; Sunitinib; Ventricular Dysfunction, Left | 2012 |
Gastro-pleuro-pericardial fistula following combined radiation and chemotherapy for lung metastases from renal cell carcinoma: report of a case.
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Chemoradiotherapy; Enzyme Inhibitors; Fistula; Gastric Fistula; Heart Diseases; Humans; Indoles; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Pericardium; Pleural Diseases; Protein-Tyrosine Kinases; Pyrroles; Sunitinib; Treatment Outcome | 2013 |
Lipid lowering in hypertension and heart protection: observations from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) and the Heart Protection Study.
Topics: Anticholesteremic Agents; Antihypertensive Agents; Atorvastatin; Cholesterol; Heart Diseases; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypolipidemic Agents; Pyrroles; Randomized Controlled Trials as Topic; Treatment Outcome | 2002 |
["Gout tophi" and heart disease in the family].
Topics: Adult; Arcus Senilis; Atorvastatin; Cholesterol; Cholesterol, HDL; Diagnosis, Differential; Female; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Heart Diseases; Heptanoic Acids; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Male; Middle Aged; Pyrroles; Time Factors; Xanthomatosis | 2003 |
The antiplatelet effect of clopidogrel is not attenuated by statin treatment in stable patients with ischemic heart disease.
Topics: Aged; Atorvastatin; Blood Platelets; Cholesterol, LDL; Clopidogrel; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Female; Heart Diseases; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemia; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Pravastatin; Pyrroles; Simvastatin; Ticlopidine; Time Factors; Wound Healing | 2005 |
Amlodipine/atorvastatin for preventing heart disease.
Topics: Amlodipine; Anticholesteremic Agents; Atorvastatin; Drug Combinations; Heart Diseases; Heptanoic Acids; Humans; Pyrroles | 2007 |
[The 2006 American Heart Association selection of the "top ten advances in heart disease and stroke research"].
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; American Heart Association; Anti-Inflammatory Agents; Anticholesteremic Agents; Atherosclerosis; Atorvastatin; Brain Ischemia; Child; Coronary Disease; Heart Diseases; Heart Valve Prosthesis; Heart-Assist Devices; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Obesity; Peptidyl-Dipeptidase A; Process Assessment, Health Care; Pyrroles; Stroke; Tissue Engineering; United States | 2007 |
Reducing myocardial injury by minimizing imbalance between oxygen supply and demand.
Topics: Anesthesiology; Animals; Atorvastatin; Blood Pressure; Cardiovascular Agents; Coronary Disease; Dogs; Heart Diseases; Heart Rate; Heptanoic Acids; History, 20th Century; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Ischemia; Myocardial Revascularization; Necrosis; Oxygen; Pyrroles | 2007 |
Effect of statin withdrawal on frequency of cardiac events after vascular surgery.
Topics: Aged; Atorvastatin; Electrocardiography; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heart Diseases; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Male; Middle Aged; Myocardial Infarction; Postoperative Complications; Pravastatin; Pyrroles; Simvastatin; Substance Withdrawal Syndrome; Troponin T; Vascular Surgical Procedures | 2007 |
Re: Pierre I. Karakiewicz, Nazareno Suardi, Claudio Jeldres, et al. Neoadjuvant Sutent induction therapy may effectively down-stage renal cell carcinoma atrial thrombi. Eur Urol 2008;53:845-8.
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Heart Diseases; Humans; Indoles; Kidney Neoplasms; Neoadjuvant Therapy; Neoplasm Staging; Neoplastic Cells, Circulating; Pyrroles; Sunitinib; Thrombosis | 2008 |